Dr. Yaqing Chen 陈雅卿
Chief Physician
Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy for cervical, endometrial, ovarian, and vulvar cancers. Focus on fertility-sparing surgery and ovarian function preservation.
Dr. Chen is Chief Physician and Deputy Director of Gynecologic Oncology Surgery at Zhejiang Cancer Hospital, with clinical research experience since August 1990. Research focuses on fertility-sparing treatments, ovarian cancer drug resistance, and targeted therapies for advanced malignancies. Dr. Chen has led or participated in over 10 health department projects, co-authored one book, published more than 40 papers, and contributed to Chinese expert consensus guidelines on ovarian cancer and uterine sarcoma.
Professional roles
- Standing Committee Member, Gynecologic Oncology Professional Committee, China Anti-Cancer Association
- Designated Chair, Gynecologic Oncology Professional Committee, Zhejiang Anti-Cancer Association
- Standing Committee Member, Obstetrics and Gynecology Branch, Zhejiang Medical Association
- Member, Gynecologic Oncology Branch, Zhejiang Medical Association
Name order: in Chinese the family name comes first (Chen Yaqing). Papers usually list the name as Yaqing Chen or Chen Y.
Selected publications
15 papers on PubMed matched by name and affiliation; 4 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Biochem Mol Toxicol, 2025 (senior author): TWIST1 Regulates FOXM1/β-Catenin to Promote the Growth, Migration, and Invasion of Ovarian Cancer Cells by Activating MFAP2. PubMed 39829397
- Funct Integr Genomics, 2023 (senior author): Advances in application of circulating tumor DNA in ovarian cancer. PubMed 37479960
- J Ovarian Res, 2021 (senior author): Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer. PubMed 33423683
- Int J Gynecol Cancer, 2017 (senior author): Clear Cell Carcinoma of the Uterine Cervix: A Clinical and Pathological Analysis of 47 Patients Without Intrauterine Diethylstilbestrol Exposure. PubMed 28498261
- Zhonghua Yi Xue Za Zhi, 2013 (senior author): [Magnetic resonance staging accuracy for endometrial carcinoma based on different FIGO staging systems]. PubMed 24029574
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion